Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Blood Research
>
2013
>
48
>
2
Volume:
48
Issue:
2
1. Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution.
Page:160—163
2. EBV-positive diffuse large B-cell lymphoma of the elderly with aberrant expression of CD3 and TIA-1.
Page:156—160
3. Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia.
Page:154—156
4. Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome.
Page:152—153
5. Pediatric chronic myeloid leukemia with B-cell lymphoid blast crisis at presentation.
Page:151—152
6. Hematological malignancies complicating beta-thalassemia syndromes: a single center experience.
Page:149—151
7. Acute colonic pseudo-obstruction following allogeneic stem cell transplantation successfully treated by neostigmine.
Page:145—148
8. Performance review of the National Blood Safety Improvement Project in Korea (2004-2009).
Page:139—144
9. Prognostic effect of blood transfusion in children with acute lymphoblastic leukemia.
Page:133—138
10. The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.
Page:128—132
11. CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.
Page:121—127
12. Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry.
Page:115—120
13. Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions.
Page:107—114
14. Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Page:99—106
15. Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations.
Page:87—98
16. Cardiovascular repair with bone marrow-derived cells.
Page:76—86
17. Peritoneal metastasis of a neuroendocrine tumor of the gallbladder.
Page:75—75
18. Internuclear bridging.
Page:74—74
19. Plerixafor use for peripheral blood stem cell mobilization in Korea.
Page:72—73
20. Towards better and safer blood transfusion.
Page:71—71